InsiderTradesSIGMA

InsidersTradesSigma

← Executives ★ Sign in to follow

SS

Sangha, Steven

OWNER 10PCT

BetterLife Pharma Inc.Sernova Biotherapeutics Inc.Goldhills Holding Ltd.

Cumul. flow

0

Total declarations

0

Companies

€960,633

▲ Purchases (11 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

11

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Explore the complete record of transactions filed by Sangha, Steven. Officer active across 3 companies, notably BetterLife Pharma Inc.. In total, 18 disclosures have been logged. Split: 11 buys · 0 sell. Total volume traded: €961k. Activity tracked since 14 April 2026. The latest transaction was disclosed on 5 August 2026 (54 - Exercise of warrants). Regulator: SEDI. All data is openly available.

Companies and markets linked to Sangha, Steven

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

BetterLife Pharma Inc. (CA)Sernova Biotherapeutics Inc. (CA)Goldhills Holding Ltd. (CA)

Declarations18 total

▲

4 - Director of IssuerExecutives14 Apr 2026Sernova Biotherapeutics Inc.

@ €0.0923Convertible DebenturesTSXSEDI:4769826

Canonical exit: 13 Jul 2026 (T+90)

●

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives5 Aug 2026BetterLife Pharma Inc.

1,000,000 sharesCommon SharesTSXSEDI:4759416

●

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives5 Aug 2026BetterLife Pharma Inc.

CA$100,00030SEDI ↗

1,000,000 shares@ CA$0.100.17% mcap32.7% of flowWarrantsTSXSEDI:4759415

●

4 - Director of IssuerExecutives4 Aug 2026Goldhills Holding Ltd.

920,660 sharesCommon SharesTSXSEDI:4758272

▲

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives22 Jun 2026BetterLife Pharma Inc.

@ €0.0369Convertible DebenturesTSXSEDI:4738529

Canonical exit: 20 Sept 2026 (T+90)

●

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives5 Jan 2024BetterLife Pharma Inc.

Convertible DebenturesTSXSEDI:4738528

◇

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives19 Jun 2026BetterLife Pharma Inc.

CA$15,00028SEDI ↗

200,000 shares@ CA$0.0750.025% mcap7.3% of flowOptionsTSXSEDI:4737728

●

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives13 Jun 2026BetterLife Pharma Inc.

CA$130,00039SEDI ↗

1,000,000 shares@ CA$0.130.22% mcap68.4% of flowWarrantsTSXSEDI:4736627

▲

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives5 Jun 2026BetterLife Pharma Inc.

CA$3,12027SEDI ↗

52,000 shares@ CA$0.060.0053% mcap5.2% of flowCommon SharesTSXSEDI:4730181

Canonical exit: 3 Sept 2026 (T+90)

▲

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives4 Jun 2026BetterLife Pharma Inc.

CA$13,74032SEDI ↗

229,000 shares@ CA$0.060.023% mcap24.1% of flowCommon SharesTSXSEDI:4728878

Canonical exit: 2 Sept 2026 (T+90)

▲

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives1 Jun 2026BetterLife Pharma Inc.

CA$7,26023SEDI ↗

121,000 shares@ CA$0.0616.9% of flowCommon SharesTSXSEDI:4726533

Canonical exit: 30 Aug 2026 (T+90)

▲

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives29 May 2026BetterLife Pharma Inc.

CA$7,56023SEDI ↗

126,000 shares@ CA$0.0621.1% of flowCommon SharesTSXSEDI:4725431

Canonical exit: 27 Aug 2026 (T+90)

▲

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives28 May 2026BetterLife Pharma Inc.

CA$7,62024SEDI ↗

127,000 shares@ CA$0.0627.0% of flowCommon SharesTSXSEDI:4724932

Canonical exit: 26 Aug 2026 (T+90)

▲

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives27 May 2026BetterLife Pharma Inc.

CA$12017SEDI ↗

2,000 shares@ CA$0.060.4% of flowCommon SharesTSXSEDI:4724931

Canonical exit: 25 Aug 2026 (T+90)

◇

4 - Director of IssuerExecutives22 May 2026Sernova Biotherapeutics Inc.

CA$41,60019SEDI ↗

260,000 shares@ CA$0.16100.0% of flowOptionsTSXSEDI:4724422

▲

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives27 May 2026BetterLife Pharma Inc.

CA$19,62025SEDI ↗

327,000 shares@ CA$0.0695.6% of flowCommon SharesTSXSEDI:4724251

Canonical exit: 25 Aug 2026 (T+90)

▲

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives26 May 2026BetterLife Pharma Inc.

CA$90023SEDI ↗

15,000 shares@ CA$0.06100.0% of flowCommon SharesTSXSEDI:4724035

Canonical exit: 24 Aug 2026 (T+90)

▲

4 - Director of IssuerExecutives14 Apr 2026Sernova Biotherapeutics Inc.

10,000,000 shares@ CA$0.15Common SharesTSXSEDI:4705035

Canonical exit: 13 Jul 2026 (T+90)

18 of 18 declarations

About Sangha, Steven

Steven Sangha is a declarant linked to BetterLife Pharma Inc. and Sernova Biotherapeutics Inc., with 13 filings in total. Across the 13 most recent filings held, buys amount to EUR 37203 and sells to EUR 0, over the period from 2026-05-26 to 2026-06-22, and the most common transaction nature is 10 - Acquisition or disposition in the public market.